Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study

Chingching Foocharoen1, Udomlack Peansukwech2, Ajanee Mahakkanukrauh1

  • 1Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

Insights

Diffuse cutaneous systemic sclerosis (dcSSc) is common in Thai patients. Early pulmonary fibrosis detection and factors like older age, high functional class, and organ involvement increase mortality risk in systemic sclerosis (SSc).

Area of Science:

  • Rheumatology
  • Dermatology
  • Pulmonology

Background:

  • Systemic sclerosis (SSc) predominantly presents as diffuse cutaneous SSc (dcSSc) in Thai patients, differing from Caucasian and some Asian populations.
  • A longitudinal study of Thai dcSSc patients is crucial for understanding disease progression and outcomes.

Purpose of the Study:

  • To characterize the clinical features of Thai SSc patients.
  • To differentiate between limited cutaneous SSc (lcSSc) and dcSSc.
  • To determine SSc mortality rates and associated risk factors.

Main Methods:

  • A cohort study of 566 adult Thai SSc patients was conducted from January 2013 to June 2019.
  • Generalized estimating equations (GEE) were used to analyze clinical differences between lcSSc and dcSSc.

Main Results:

  • The majority of patients were female (72.6%) and had dcSSc (72.6%).
  • Pulmonary fibrosis (PF) was detected early (median 2.5 years), with pulmonary arterial hypertension and renal crisis occurring later.
  • dcSSc correlated with specific skin manifestations (salt-and-pepper, deformity) and higher modified Rodnan skin scores (mRSS).
  • Mortality risk factors included older age at onset, high World Health Organization functional class (FC III/IV), edematous skin, early PF, higher mRSS, and multiple organ involvement.

Conclusions:

  • Diffuse cutaneous systemic sclerosis (dcSSc) is the predominant subtype in Thailand.
  • Pulmonary fibrosis (PF) is an early complication of SSc, and its early detection indicates a poorer prognosis.
  • Factors such as advanced age at onset, severe functional limitation, extensive skin involvement, and multi-organ disease significantly increase mortality risk in SSc patients.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
363
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
336
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
400
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
253
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
143
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
215